Labshake search
Citations for R&D Systems :
51 - 100 of 1662 citations for G CSF Mouse CHO since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... 10ng/mL GM-CSF (R&D Systems, 215-GM) with 250nM dasatinib (Selleck Chemicals ...
-
bioRxiv - Immunology 2021Quote: Recombinant CSF-1 (4 µg/dose; R&D Systems) was given to EAE mice on days 4 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... and GM-CSF (50 ng/ml, R&D Systems) for seven days ...
-
bioRxiv - Immunology 2021Quote: ... 40ng/ml of rm M-CSF (R&D System) and allowed to differentiate for 7 days.
-
bioRxiv - Immunology 2020Quote: ... and 800 U/mL GM-CSF (R&D Systems) for 6 days ...
-
bioRxiv - Immunology 2021Quote: ... and GM-CSF (50 ng/mL, R&D Systems). For macrophage differentiation ...
-
bioRxiv - Microbiology 2022Quote: ... plus 10 ng/mL M-CSF (R&D Systems). Fully differentiated MDMs were maintained in media containing RPMI 1640 plus 10% dialyzed FBS ...
-
bioRxiv - Microbiology 2023Quote: ... and 10 ng/mL M-CSF (R&D Systems). On Day 2 and Day 4 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... and anti-M-CSF (#AF416 from R&D Systems). Detection was performed using peroxidase-coupled secondary antibody ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 25 ng/mL M-CSF (R&D Systems) for 2 days ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 ng/ml rhM- CSF (R&D Systems).
-
bioRxiv - Neuroscience 2024Quote: ... and 10 ng/ml GM-CSF (R&D System)] and plated onto 12 mm glass coverslips ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 50 ng/mL mGM-CSF (R&D Systems, USA) and 4 ng/mL mIL-4 (Peprotech ...
-
bioRxiv - Molecular Biology 2022Quote: ... from C57BL/6 mice were differentiated from proliferating mouse bone marrow progenitors through induction with 20 ng/ml granulocyte macrophage colony stimulating factor (GM-CSF) (R&D Systems, USA) over 6–9 days as described [35] ...
-
bioRxiv - Microbiology 2023Quote: ... The cells were then incubated in the presence of 50 ng/mL of GM-CSF (02532, Stem Cells, Vancouver, Canada) and 50 ng/mL of M-CSF (216-MC, R&D Systems, Minneapolis, USA) at 37°C and 5% CO2 for differentiation ...
-
bioRxiv - Microbiology 2020Quote: ... GM-CSF and IL-3 [all from R&D Systems]) ...
-
bioRxiv - Microbiology 2020Quote: ... + 50 ng/ml M-CSF (R&D Systems, https://www.rndsystems.com) and 50 ng/ml GM-CSF + 500 U/ml IL-4 (Biolegend ...
-
bioRxiv - Immunology 2021Quote: ... GM-CSF and CCL5 from R&D Systems (Minneapolis, USA), IFNγ from Biolegend (San Diego ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... and 30ng/ml M-CSF (R&D Systems, Abingdon, UK) and incubated in T75 flasks for 24h at 37°C ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL GM-CSF (R&D Systems 215-GM), and 3 U/mL EPO (R&D Systems 287-TC) ...
-
bioRxiv - Cell Biology 2022Quote: ... 40 ng/mL M-CSF (R&D Systems, 416-ML). The cells were then incubated with osteoclastogenesis medium ...
-
bioRxiv - Immunology 2020Quote: ... and 20 ng GM-CSF (R&D systems, Minneapolis, MN) per ml medium ...
-
bioRxiv - Immunology 2020Quote: ... containing 20 ng/mL M-CSF (R&D System, USA) on 10-cm petri dishes and renewed the medium every other day ...
-
bioRxiv - Pathology 2022Quote: ... and 25 ng/mL M-CSF (R&D Systems, USA). The medium was changed every three days until the BMMs reached 95% confluency ...
-
bioRxiv - Immunology 2023Quote: ... and 50 ng/ml of GM-CSF (R&D Systems) (G4 Media ...
-
bioRxiv - Cell Biology 2024Quote: ... and 20ng/mL M-CSF (R&D Systems: 416-ML) at 37°C and 5% CO2 ...
-
bioRxiv - Molecular Biology 2024Quote: ... 10 ng/mL rhGM-CSF (R&D Systems Minneapolis, MN) and 25 ng/mL rhM-CSF (R&D Systems Minneapolis ...
-
bioRxiv - Physiology 2021Quote: ... primary osteoclast precursors were seeded after initial culture on non-treated plates into 6 well plates in the presence of 30ng/mL recombinant mouse M-CSF (R&D systems, Minneapolis, MN) for 3 days ...
-
bioRxiv - Immunology 2021Quote: ... the bone marrow cells were culture in 6-well plates at density of 3×106 cells/mL in 3mL DC medium in the presence of mouse granulocyte macrophage-colony stimulating factor (GM-CSF; 1000 U/mL; R&D Systems, Minneapolis, MN) and interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2024Quote: ... and differentiated into M1 or M2 macrophages by incubation for 7 days in the presence of 100 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-colony stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA), respectively.
-
bioRxiv - Immunology 2023Quote: ... supernatants were collected and concentrations of IFN-γ and GM-CSF were determined using ELISA kits from R&D Systems (IFN-γ; DIF50C, GM-CSF; DGM00) according to the manufacturer’s instructions.
-
bioRxiv - Neuroscience 2021Quote: ... and treated with GM-CSF (2.5 ng/mL; R&D Systems) to enhance microglial proliferation ...
-
bioRxiv - Microbiology 2021Quote: ... and 20 ng/ml of M-CSF (R&D System, USA). The coculture of BMMs with MSCs was done using a transwell system (0.4 µm pore size ...
-
bioRxiv - Cell Biology 2021Quote: ... monocyte colony stimulating factor (M-CSF, 20ng/mL, R&D Systems). EOC2 cultures were maintained in DMEM media supplemented with 10% HI FBS ...
-
bioRxiv - Biochemistry 2021Quote: ... and 50 ng/mL GM-CSF (215-GM, R&D systems) and seeded in 96-well plates (105/well ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems), and recombinant IL-34 (IL-34 ...
-
bioRxiv - Immunology 2020Quote: ... CSF-1 was measured by standardized sandwich ELISA (R&D Systems).
-
bioRxiv - Biochemistry 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems; #416-ML) and plated into 6-well tissue culture plates ...
-
bioRxiv - Immunology 2020Quote: ... and 50 ng/mL GM-CSF (215-GM; R&D Systems). KhES1 ESCs were kindly provided by Dr ...
-
bioRxiv - Immunology 2023Quote: ... and M-CSF by the ELISA kit from R&D Systems; Multiplex suspension array (IL-4 ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 50 ng/mL human GM-CSF (R&D Systems) to stimulate macrophage differentiation ...
-
bioRxiv - Molecular Biology 2024Quote: ... and 25 ng/mL rhM-CSF (R&D Systems Minneapolis, MN). On day 13 adherent macrophages were harvested using Trypsin-EDTA (0.25% ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant macrophage-colony stimulating factor (M-CSF, R&D Systems), Lysoview-633 (biotium) ...
-
bioRxiv - Immunology 2022Quote: ... immobilized hIgG, or 50 ng/ml recombinant GM-CSF (rGM-CSF) (Bioscience, US) plus 20 ng/ml IL-4 (R&D systems Cat.No. 204-IL-010, US), for 5 days to obtain immature dendritic cells (iDC) ...
-
bioRxiv - Cell Biology 2019Quote: Reagents were obtained as follows: M-CSF (R&D Systems, Abingdon, UK), RANKL (Peprotech ...
-
bioRxiv - Immunology 2019Quote: ... carrier-free M-CSF (50 ng/ml, R&D Systems, Minneapolis, Minnesota) and GM-CSF (50 ng/ml ...
-
bioRxiv - Immunology 2021Quote: GM-CSF (Granulocyte Macrophage Colony Stimulating Factor) (R&D Systems, Minneapolis, USA), M-CSF (Macrophage Colony Stimulating Factor ...
-
bioRxiv - Immunology 2021Quote: ... or M-CSF (25 ng/mL, 216-MC-025, R&D Systems) in the presence or absence of purified β-glucan from Candida albicans (10 μg/mL unless otherwise stated ...
-
bioRxiv - Immunology 2021Quote: ... in the presence of M-CSF (50 ng/mL, R&D Systems) and GM-CSF (50 ng/mL ...